Skip to content

A comparative clinical study to evaluate the effect of Shalmali Ghritha and Bola Baddha Rasa in Asrigdara (DUB)

A randomized controlled clinical study to evaluate the efficacy of Shalmali Ghritha in Asrigdara (DUB) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058973
Enrollment
40
Registered
2023-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding

Interventions

None listed

Sponsors

Akshata Mallikarjun Mudalagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Raja Atipravarthi – Excessive Bleeding ( >/ 6 pads fully soaked per day ). 2.Deerga kala anubandhi – Prolonged Bleeding ( >/ 8 days) , pervious H/O atleast 2 consecutive cycles. 3.Vedana – Pain 4.Age : 20 - 45 years 5.Patient with HB% > 8gm% 6.Both married and unmarried

Exclusion criteria

Exclusion criteria: 1.Patient with history of DM, HTN, Bleeding disorders and other systemic disorders. 2.Pregnant and Lactating females. 3.Any pelvic pathologies like Endometriosis, Fibroids, Tumor, Inflammation, Benign and Malignant growth in uterus. 4.Post Abortal Bleeding. 5.Endocrinal disorders like Thyroid Dysfunction, PCOS . 6.IUCD and OCP user.

Design outcomes

Primary

MeasureTime frame
1.Prolonged cycle (YES/NO) 2.Duration of menstrual bleeding 3.Excessive bleeding (YES/NO) 4.Amount of menstrual bleeding 5.Pain Timepoint: During treatment 3rd day & 11th day

Secondary

MeasureTime frame
1.Prolonged cycle (YES/NO) 2.Duration of menstrual bleeding 3.Excessive bleeding (YES/NO) 4.Amount of menstrual bleeding 5.Pain Timepoint: After treatment 3rd day & 11th day of next 2 consecutive menstrual cycle.

Countries

India

Contacts

Public ContactAkshata Mallikarjun Mudalagi

Alvas Ayurveda Medical College , Moodbidri

drasokan24@gmail.com6361740431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026